Source:
Highlights
Pfizer on Monday said it told India that there was no concern over safety of its COVID-19 vaccine.
Pfizer said the safety and efficacy data had been backed by regulatory authorities in US, Britain, Japan, WHO.
India has invited Pfizer, Johnson & Johnson and Moderna Inc to sell their vaccines to the country but none have applied to do so yet.
NEW DELHI: Pfizer Inc said on Monday it told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as the country insists on small local trials for foreign shots despite a record surge in infections and shortage of doses.
URL copied
More data confirm single dose of Pfizer, AstraZeneca vaccines work
Scientists at Oxford University have released more data that confirm coronavirus vaccines made by Pfizer-BioNTech and AstraZeneca both significantly cut the risk of infection after a single dose. In studies published on Friday, researchers said there was no apparent difference in the vaccines ability to reduce COVID-19 infection rates.
The research has not yet been published in a peer-reviewed journal but is based on data from nose and throat swabs taken from more than 370,000 participants in England and Wales between December and April.
The scientists said that three weeks after people had been given a single dose of either the Pfizer-BioNTech or AstraZeneca vaccine, the rates of all COVID-19 infections fell by 65 per cent. The reduction was bigger after a second dose and the vaccines appeared to protect people against the variant that was first identified in the UK.
If you have been administered the Pfizer coronavirus vaccine, you might need a third dose, as per the company’s CEO Albert Bourla.
The CEO has claimed that people may need a booster shot within 12 months of fully getting vaccinated.
Watch |
06 April 2021 - 11:51 By Reuters The first batch of 20 million Pfizer Covid-19 vaccines are expected to arrive in SA at the end of the month. Image: REUTERS/DADO RUVIC SA has signed an agreement with Pfizer Inc for 20 million dual-shot Covid-19 vaccine doses, a government official told Reuters on Tuesday, boosting plans to start mass vaccinations from April.
The deal is another fillip for the country worst hit by Covid-19 infections in Africa, as it adds to the 31 million single-shot doses from Johnson & Johnson (J&J) which the government approved last Thursday.
The first batch from Pfizer is expected to arrive late in April, deputy director-general at the department of health Anban Pillay told Reuters, but he did not comment on the price.
MOSCOW (Sputnik) - A suggestion by US scientists, that Russia s Sputnik V coronavirus jab is less effective against the South African strain, is inaccurate, given that.